Format

Send to

Choose Destination
J Microbiol Biotechnol. 2015 Nov;25(11):1966-9. doi: 10.4014/jmb.1506.06065.

A Double-Blind, Placebo Controlled-Trial of a Probiotic Strain Lactobacillus sakei Probio-65 for the Prevention of Canine Atopic Dermatitis.

Author information

1
Haemaru Referral Animal Hospital, Sungnam 463-050, Republic of Korea.
2
Department of Applied Microbiology and Biotechnology, Yeungnam University, Gyeongsan 712-749, Republic of Korea.
3
National Science Museum Ministry of Science, ICT and Future Planning, Daejeon 305-705, Republic of Korea.
4
proBionic, Yusung, Daejeon 305-333, Republic of Korea.

Abstract

Canine atopic dermatitis (CAD) is a ubiquitous, chronic inflammatory skin disorder prevalent in dogs, which results in production of abnormal levels of IgE antibodies in reciprocation to an allergen challenge. In this study, administration of the probiotic strain Lactobacillus sakei probio-65 for 2 months significantly reduced the disease severity index in experimental dogs diagnosed with CAD. In addition, one month pre-medication of L. sakei probio-65 revealed significant difference in the PVAS score in experimental dogs for both probio-65 and placebo groups. However, post 2 months treatment resulted in a significant decrease in the CASESI score values in the probio-65-treated group (p < .0.06).

KEYWORDS:

Canine atopic dermatitis; Lactobacillus sakei; probiotics; skin disorder

PMID:
26282691
DOI:
10.4014/jmb.1506.06065
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for The Korean Society for Microbiology and Biotechnology.
Loading ...
Support Center